uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Xyndari
Application withdrawn
Human
Orphan medicine
Details
EMA number
EMEA/H/C/004734
ATC code
A16AA03
Authorisation
-
Revision
-
EMA page
Therapeutic indication
Treatment of sickle cell disease.
MeSH:
Anemia, Sickle Cell
Group:
Other alimentary tract and metabolism products
Marketing Authorisation Holder
Emmaus Medical Europe Ltd
MAH
Xyndari | uMedical